Cargando…
Personalized Medicine’s Bottleneck: Diagnostic Test Evidence and Reimbursement
Background: Personalized medicine is gradually emerging as a transformative field. Thus far, seven co-developed drug-diagnostic combinations have been approved and several dozen post-hoc drug-diagnostic combinations (diagnostic approved after the drug). However, barriers remain, particularly with re...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263971/ https://www.ncbi.nlm.nih.gov/pubmed/25563222 http://dx.doi.org/10.3390/jpm4020163 |